State of Wisconsin Investment Board
CUE icon

State of Wisconsin Investment Board’s Cue Biopharma CUE Stock Holding History

State of Wisconsin Investment Board’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,320
Closed -$483K – 2088
2021
Q1 		$483K Sell
1,320
-773
-37% -$318K ﹤0.01% 1613
2020
Q4 		$786K Sell
2,093
-97
-4% -$38.8K ﹤0.01% 1394
2020
Q3 		$989K Buy
2,190
+1,003
+84% +$578K ﹤0.01% 1296
2020
Q2 		$873K Buy
1,187
+160
+16% +$116K ﹤0.01% 1264
2020
Q1 		$437K Buy
+1,027
New +$498K ﹤0.01% 1377
2019
Q3 		– Sell
-820
Closed -$221K – 1548
2019
Q2 		$221K Buy
820
+17
+2% +$4.23K ﹤0.01% 1480
2019
Q1 		$186K Buy
803
+186
+30% +$35.4K ﹤0.01% 1468
2018
Q4 		$87K Buy
+617
New +$112K ﹤0.01% 1503

Other funds holding CUE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wisconsin Investment Board's CUE Position: Q2 2021 in Review

State of Wisconsin Investment Board sold out of Cue Biopharma (CUE) in Q2 2021, closing a stake of 1,320 shares — an estimated $483K sold.

State of Wisconsin Investment Board first reported a position in CUE in Q4 2018 and held it in 8 quarters. The position peaked at $989K in Q3 2020. 89 funds tracked by Wall St. Rank hold CUE as of Q2 2021.

  • State of Wisconsin Investment Board reported no remaining Cue Biopharma position as of Q2 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 1,320 Cue Biopharma shares in Q2 2021, an estimated $483K.
  • State of Wisconsin Investment Board first reported a position in Cue Biopharma in Q4 2018 and held it in 8 quarters.
  • State of Wisconsin Investment Board's Cue Biopharma position peaked at $989K in Q3 2020.
  • 89 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2021, filed 12 Aug 2021.